## Abstract Apixaban is a potent inhibitor of blood coagulation Factor Xa in the late stages of development. [^14^C]apixaban was synthesized with the 14C label in the two different lactam ring systems within the molecule for various __in vitro__ and __in vivo__ metabolism studies. A nine‐step synth
A coagulation factor becomes useful in the study of acute leukemias: Studies with blood coagulation factor XIII
✍ Scribed by Flóra Kiss; Ágnes Simon; László Csáthy; Zsuzsanna Hevessy; Éva Katona; Csongor Kiss; János Kappelmayer
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 375 KB
- Volume
- 73A
- Category
- Article
- ISSN
- 0196-4763
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract In the present work we have bound Pluronic™, a class of triblock copolymers consisting of a block of polypropylene oxide (PPO) surrounded on each side by polyethylene oxide (PEO) blocks, to polystyrene surfaces and investigated the thrombogenicity and complement activation of this const
## Abstract ## Background Intronic sequences have the potential to improve gene expression in eukaryotes by a variety of mechanisms. In this context, human β‐globin (__hBG__) introns were inserted into the human factor __IX__ (__hFIX__) cDNA in cytomegalovirus (CMV)‐regulated plasmids. The resulti
BACKGROUND. Chronic disseminated candidiasis (CDC) is a serious complication of treatment in patients with acute leukemia. Although some general risk factors are known to predispose to systemic fungal infections, few studies have addressed the relevance of certain clinical and laboratory features in
## Abstract Coagulation in blood is initiated when coagulation factor VII (FVII) binds to exposed TF and is activated to FVIIa, and the TF/FVIIa complex may therefore provide a marker of vascular injury potentially applicable in diagnostic imaging of acute gastrointestinal (GI) bleeding. Methods: R